PAMAM Dendrimers as Potential Agents against Fibrillation of α-Synuclein, a Parkinson's Disease-Related Protein

被引：58
|
作者：
Rekas, Agata [1 ]
Lo, Victor [1 ]
Gadd, Gerry E. [1 ]
Cappai, Roberto [2 ]
Yun, Seok I. [1 ]
机构：
[1] Australian Nucl Sci & Technol Org, Menai, NSW 2234, Australia
[2] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
来源：
MACROMOLECULAR BIOSCIENCE | 2009年 / 9卷 / 03期
关键词：
alpha-synuclein; amorphous; amyloid; dendrimers; neutron scattering; ANGLE NEUTRON-SCATTERING; ALZHEIMERS-DISEASE; AMYLOID PEPTIDES; MOLECULAR CHAPERONE; AGGREGATION; DEPENDENCE; INCLUSIONS; CRYSTALLIN; COMPONENT; NACP;
D O I：
10.1002/mabi.200800242
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The effect of PAMAM dendrimers (generations G3, G4 and G5) on the fibrillation of a-synuclein was examined by fluorescence and CD spectroscopy, TEM and SANS. PAMAM dendrimers inhibited fibrillation of a-synuclein and this effect increased both with generation number and PAMAM concentration. SANS showed structural changes in the formed aggregates of alpha-synuclein - from cylindrical to dense three-dimensional ones-as the PAMAM concentration increased, on account of the inhibitory effect. PAMAM also effectively promoted the breaking down of pre-existing fibrils of alpha-synuclein. In both processes-that is, inhibition and disassociation of fibrils-PAMAM redirected alpha-synuclein to an amorphous aggregation pathway.
引用
收藏
页码：230 / 238
页数：9
相关论文
共 50 条
  • [1] TiO2 Nanoparticles as Potential Promoting Agents of Fibrillation of α-Synuclein, a Parkinson's Disease-Related Protein
    Mohammadi, Soheila
    Nikkhah, Maryam
    IRANIAN JOURNAL OF BIOTECHNOLOGY, 2017, 15 (02) : 87 - 94
  • [2] Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma
    Matsuo, Yasuhiro
    Kamitani, Tetsu
    PLOS ONE, 2010, 5 (05):
  • [3] Effect of hormones and hormone mimetics on fibrillation of Parkinson's disease-related protein u-synuclein
    Perlow, Gabriel L.
    Myers, Jeffrey K.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [4] Structural Insights into Amyloid Oligomers of the Parkinson Disease-related Protein α-Synuclein
    Ignacio Gallea, J.
    Soledad Celej, M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (39) : 26733 - 26742
  • [5] Mechanisms of enhanced aggregation and fibril formation of Parkinson's disease-related variants of α-synuclein
    Ohgita, Takashi
    Namba, Norihiro
    Kono, Hiroki
    Shimanouchi, Toshinori
    Saito, Hiroyuki
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice
    Aniszewska, Agata
    Bergstrom, Joakim
    Ingelsson, Martin
    Ekmark-Lewen, Sara
    BRAIN AND BEHAVIOR, 2022, 12 (07):
  • [7] Relationship of Apolipoprotein E to Parkinson's disease-related alpha-synuclein pathology
    Parkkinen, L.
    Joachim, C.
    Esiri, M. M.
    Ansorge, O.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2013, 39 : 37 - 37
  • [8] Mechanisms of enhanced aggregation and fibril formation of Parkinson’s disease-related variants of α-synuclein
    Takashi Ohgita
    Norihiro Namba
    Hiroki Kono
    Toshinori Shimanouchi
    Hiroyuki Saito
    Scientific Reports, 12
  • [9] Phosphorylated α-synuclein as a potential biomarker for Parkinson's disease and related disorders
    Foulds, Penelope
    Mann, David M. A.
    Allsop, David
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2012, 12 (02) : 115 - 117
  • [10] Identification of Parkinson's disease-related pathways and potential risk factors
    Shen, Jun
    Chen, Xiao-Chang
    Li, Wang-Jun
    Han, Qiu
    Chen, Chun
    Lu, Jing-Min
    Zheng, Jin-Yu
    Xue, Shou-Ru
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (10)
12345